Immunotherapy for Head and Neck Squamous Cell Carcinoma.

scientific article published on 20 October 2015

Immunotherapy for Head and Neck Squamous Cell Carcinoma. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/J.HOC.2015.07.009
P698PubMed publication ID26568546

P2093author name stringJohn B Sunwoo
David W Schoppy
P2860cites workTargeting CD137 enhances the efficacy of cetuximab.Q33872482
P433issue6
P921main subjectimmunotherapyQ1427096
P304page(s)1033-1043
P577publication date2015-10-20
P1433published inHematology / Oncology Clinics of North AmericaQ15749192
P1476titleImmunotherapy for Head and Neck Squamous Cell Carcinoma.
P478volume29

Reverse relations

cites work (P2860)
Q50066270BCG immune activation reduces growth and angiogenesis in an in vitro model of head and neck squamous cell carcinoma
Q39190801Biological mechanisms of immune escape and implications for immunotherapy in head and neck squamous cell carcinoma
Q59477539Costimulatory and coinhibitory immune checkpoint receptors in head and neck cancer: unleashing immune responses through therapeutic combinations
Q90419584Current Perspectives in Cancer Immunotherapy
Q39084115Current insights into the aetiology, pathobiology, and management of local disease recurrence in squamous cell carcinoma of the vulva
Q90734623Distinguishing Features of Cetuximab and Panitumumab in Colorectal Cancer and Other Solid Tumors
Q33650470Evidence-Based Treatment Options in Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck
Q57475700Immunotherapy for Brain Tumors
Q39308337Immunotherapy for Head and Neck Squamous Cell Carcinoma: A Review of Current and Emerging Therapeutic Options
Q40208391PDCD1 (PD-1) promoter methylation predicts outcome in head and neck squamous cell carcinoma patients
Q46113809Rationale for combination of therapeutic antibodies targeting tumor cells and immune checkpoint receptors: Harnessing innate and adaptive immunity through IgG1 isotype immune effector stimulation
Q91895909The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of squamous cell carcinoma of the head and neck (HNSCC)
Q90649378The multifarious roles of the chemokine CXCL14 in cancer progression and immune responses

Search more.